Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy

Cancers (Basel). 2022 May 15;14(10):2438. doi: 10.3390/cancers14102438.

Abstract

Hundreds of lymph nodes (LNs) are scattered throughout the body. Although each LN is small, it represents a complete immune organ that contains almost all types of immunocompetent and stromal cells functioning as scaffolds. In this review, we highlight the importance of LNs in cancer immunotherapy. First, we review recent reports on structural and functional properties of LNs as sites for antitumor immunity and discuss their therapeutic utility in tumor immunotherapy. Second, we discuss the rationale and background of ultrasound (US)-guided intranodal injection methods. In addition, we review intranodal administration therapy of tumor-specific-antigen-pulsed matured dendritic cells (DCs), including neoantigen-pulsed vaccines.

Keywords: cancer vaccines; dendritic cells; intranodal; lymph nodes; neoantigen; peptides; stromal cells.

Publication types

  • Review

Grants and funding

This study was supported by the Japan Society for the Promotion of Science KAKENHI, grant numbers JP19K09047, JP21K08672, and JP19K2266.